50
C.N. Britos et al. / Journal of Molecular Catalysis B: Enzymatic 79 (2012) 49–53
(Argentine). TLC aluminium sheets (Silica gel 60 F254) were from
Merck (Germany).
2.9. Analytical methods
Nucleoside analog biotransformations were qualitatively
evaluated by TLC in 80:20 (v/v) chloroform/methanol as mobile
phase. The quantitative analysis was performed by HPLC (Phar-
2.2. Growth conditions
macia LKB) at 254 nm using
a
Nucleodure 100C–18column
Microorganisms were grown until saturation, harvested by cen-
trifugation during 10 min at 17,500 × g, washed with 50 mM pH
7 tris(hydroxymethyl)aminomethane–HCl (Tris–HCl) buffer and
stored at 4 ◦C until use. Lactobacillus media contained 15 g/L tryp-
tone, 5 g/L soy peptone, 5 g/L NaCl pH 7. Lactococcus media: 10 g/L
tryptone, 15 g/L meat peptone, 10 g/L yeast extract, 10 g/L glucose,
1 g/L Tween® 80 pH 6.5.
(5 m, 125 mm × 5 mm). Isocratic mobile phases used were
water/methanol at the following ratios: (95:5, v/v) for 5-
fluoruracil-2ꢀ-deoxyriboside (5FUradRib); (90:10, v/v) for
5-bromouracil-2ꢀ-deoxyriboside (5BrUradRib), 6-chloropurine-
2ꢀ-deoxyriboside (6ChPurdRib), 6-bromopurine-2ꢀ-deoxyriboside
(6BrPurdRib)
and
6-chloro-2-fluoropurine-2ꢀ-deoxyriboside
(6Ch2FPurdRib) and (99:1, v/v) for 5-chlorouracil-2ꢀ-deoxyriboside
(5ChUradRib) biotransformations. Product identification was per-
formed by MS–HPLC LCQ-DECAXP4 Thermo Spectrometer with
Electron Spray Ionization method (ESI). Phenomenex C18 column
(5 m, 100 mm × 2 mm) and Xcalibur 1.3 software (Thermo-
Finnigan, USA) were used. Mobile phase used for 5FUradRib (t:
14.0 min, M+: 246.9) and 5BrUradRib (t: 34.4 min, M+: 308.0)
biotransformations was 95/5 (v/v) water/methanol + 0.1% acetic
acid and flow was 200 L/min. Mobile phase used for 6ChPurdRib
(t: 4.2 min, M+: 271.8) and 6BrPurdRib (t: 9.4 min, M+: 315.8)
biotransformations was 15/85 (v/v) water/methanol + 0.1% acetic
acid and flow was 200 L/min.
2.3. Standard reaction
5FUradRib biotransformation was carried out with 1 × 1010
colony-forming units (CFU), 6 mM thymidine (dThd) and 2 mM 5-
fluorouracil (5FUra) in 50 mM pH 7 Tris–HCl buffer at 30 ◦C and
shaking at 200 rpm. Assays were performed three times.
2.4. Lactic acid bacteria selection
Lactococcus (L. lactis subps. lactis and L. lactis subsp. cremoris)
and Lactobacillus strains (Lactobacillus acetotolerans and L. animalis)
were used to assay NDT activity at 3 h in standard conditions [13].
3.1. Lactic acid bacteria selection
2.5. Sugar donor selection
Floxuridine biotransformation was assayed to select the best
LAB (Scheme 1). Screening was carried out with several Lactococcus
and Lactobacillus strains. L. lactis subsp. cremoris and L. acetotolerans
showed no significant activity (less than 5%) whereas L. animalis
ATCC 35046 exhibited the highest NDT activity (48% at 3 h).
Different ribosides such as thymidine (dThd), uridine (Urd), 2ꢀ-
deoxyuridine (dUrd), uracil 1--d-arabinofuranoside (araUra) and
2ꢀ,3ꢀ-dideoxyuridine (ddUrd) were assayed as sugar donors. Reac-
tions were made with 1 × 1010 CFU/mL in 1 mL of 2.5 mM riboside
and 50 mM pH 7 Tris–HCl buffer, 30 ◦C at 3 h.
3.2. Sugar donor selection
2.6. Optimization of bioprocess parameters
Urd, dThd, dUrd, ddUrd and araUra were tested as starting ribo-
sides. L. animalis ATCC 35046 preferentially hydrolyzed dThd and
dUrd with yields of 38% and 35% at 3 h, respectively. Urd was
also hydrolyzed, although with lower yield (22% at 3 h). However,
when ddUrd and araUra were assayed, no hydrolytic activity was
detected. In view of these results, dThd was used as starting 2ꢀ-
deoxyriboside for 5FUradRib biotransformation.
Different reaction parameters such as different growth phases
of microorganism (stationary and exponential), buffer concentra-
tion (10, 25, 50 and 75 mM) and cation effect (1 and 10 mM Mg2+
,
K+, Zn2+, Ca2+, Cu2+, Mn2+ or Ba2+) were studied for 5FUradRib bio-
transformation in standard conditions.
Additionally, reaction time (0.25, 0.5, 1, 3 and 6 h), amount of
microorganisms (1 × 108, 1 × 109, 5 × 109 and 1 × 1010), different
reaction temperatures (20, 30, 45 and 60 ◦C), pH (6, 7 and 8) and
different 5FUra and dThd relations (2:2, 6:2 and 2:6 mM) were
evaluated.
3.3. Optimization of bioprocess parameters
5FUradRib biotransformation from dThd and 5FUra was used to
optimize bioprocess parameters at different reaction times.
2.7. Whole cells immobilization
3.3.1. Effect of microbial growth phase
L. animalis ATCC 35046 (1 × 1010 CFU) was immobilized by
entrapment in agar, agarose, polyacrylamide and sodium algi-
nate as previously described [14]. For adsorption immobilization,
200 mg of EDA-Sepharose, IDA-Agarose, DEAE-Sepharose or Q-
Agarose were incubated with 1 × 1010 CFU in 1 mL of 50 mM pH
7 Tris–HCl buffer, during 16 h at 30 ◦C and shaking at 200 rpm.
5FUradRib biotransformation was assayed using L. animalis at
exponential and stationary microbial growth phases. 5FUradRib
conversions were 48% and 71% in the exponential and stationary
phase at 1 h, respectively. This result could be due to differential
expression of NDT, an enzyme involved in the pyrimidine salvage
2.8. Biotransformation of other halogenated 2ꢀ-deoxyribosides
3.3.2. Effect of Tris–HCl concentration
Different Tris–HCl concentrations were assayed (10–75 mM)
(Fig. 1A). The highest activity was observed when the buffer con-
centration was 25 mM (43 mg/L h), while at lower (10 mM) or
higher (50 mM) Tris–HCl concentrations no significant variations
in productivity were detected. A decrease in enzyme activity was
Other purine and pyrimidine bases were tested: 5-bromouracil
(5BrUra), 5-chlorouracil (5ChUra), 6-chloropurine (6ChPur), 6-
bromopurine (6BrPur) and 6-chloro-2-fluoropurine (6Ch2FPur).
The reactions were performed at optimized conditions.